This review updates the surgeon about the cellular, matrix, and growth factor components of scarless fetal wound repair.
the time of surgery, the less likely he/she will be born with surgical scars. How does this happen? A summary of some of the phenomenologic differences between adult and fetal repair is shown in Table 1 .
We propose that scarless fetal repair is a consequence of a unique extracellular matrix produced by the fetal fibroblast in the absence of an adult-like inflammatory response to injury. Unraveling the biology of fetal repair has led to novel strategies for the prevention and treatment of scarring and fibrosis.
THE FETAL ENVIRONMENT
There are multiple differences between the fetal and adult environment that can influence wound repair. Finally, the profile of growth factors in fetal and adult serum are different e.g., fetal serum contains much higher levels of insulin-like growth factor II and hyaluronic acid stimulating factor.4 '5 Basically, there are two ways to evaluate the role ofthe environment in the fetal wound healing process -either put adult skin in the fetal environment, or place fetal skin in the adult environment, then determine the effect of the environment on healing. To investigate the influence of the fetal environment in modulating postnatal wound healing, we transplanted adult sheep skin onto 60-day gestation (term = 145 days) fetal lambs. 6 In this experiment, the engrafted adult skin is bathed in amniotic fluid, perfused by fetal blood, and the immature fetal immune system will not reject the adult skin graft. The adult grafts were wounded 40 days later (100 days gestation), at a time at which scarless repair occurs in fetal sheep. The wounds were analyzed by collagen immunohistochemistry and were shown to heal with scar formation. Neither an amniotic fluid environment nor perfusion by fetal blood prevented scar formation in the wounded adult skin graft. This study suggests that scarless fetal skin healing properties are intrinsic to fetal skin and are not caused by the fetal environment.
Support for this concept comes from the flip side experiment -fetal tissue healing in the adult environment. Ferguson and colleagues at the University of Manchester in England have done these experiments using an opossum called the Monodelphus domesticus. At birth, the opossum is physiologically and functionally a fetus and the pouch young remain attached to the mother's nipple for 4 weeks after birth. So the "fetal" development of this marsupial continues in this nonsterile environment and in the absence of amniotic fluid. Wounded 2-day old pouch young heal rapidly and scarlessly outside of the sterile, fluid uterine environment, whereas older animals show extensive scarring.7 Similarly, using novel in vitro systems, both Ihara and Martin have shown that isolated fetal rat or mouse tissue grown in organ culture media can heal wounds without scar formation.89 Thus, amniotic fluid and fetal blood components, such as platelets, are not required for scarless repair.
Despite a relatively constant intrauterine environment, fetuses heal without scar early in gestation and begin to scar late in gestation.'1 We have studied the temporal sequence of repair outcomes in early, mid, and late gestation fetal rhesus monkeys. Early gestation primate lip wounds heal with regeneration of all skin elements, including collagen, hair follicles, sebaceous glands, and even muscle in the deeper tissue layers. However, as gestation proceeds, the primate fetus first loses its ability to regenerate normal hair follicle and other appendage patterns, but remains able to restore a normal, reticular collagen pattern after wounding. This pattern of "transition" wound repair is not regeneration or classic scar because the wound collagen organization is unchanged from skin that is not wounded. By the early third trimester, a complete switch to adult-type repair occurs with wounds showing densely packed, disorganized collagen deposition characteristic of scar."
The experiments described in this section led to the hypothesis that fetal healing must involve different cellular and connective tissue events than adult repair, and that this process is independent of the unique fetal environment. In addition, we have learned that the type of healing result in fetal animals also depends on 1) the extent of tissue damage -large excisional fetal skin wounds scar earlier in gestation than incisional wounds'2; 2) the type of tissue that is injured -internal fetal tissues, such as the diaphragm muscle, stomach, and peritoneum, heal with scar formation'3; and 3) the species of animal fetal rabbits do not heal excisional skin wounds. ' The identification ofcytoskeletal differentiation markers in fibroblasts has led to the recognition of their phenotypic heterogeneity. During wound healing and fibrocontractive diseases in the adult, some fibroblasts acquire morphologic and biochemical features of smooth muscle cells (myofibroblasts), including the expression ofalpha-smooth muscle actin (ASMA).20 In turn, ASMA expression and myofibroblast function can be modulated by the wound matrix and growth factors,2' and these interactions change during development. 22 We have investigated the role of the myofibroblast in fetal sheep tissue repair using ASMA immunohistochemistry and transmission electron microscopy for myofibroblast detection. Small excisional wounds in the fetal lamb heal without scar formation or contraction at 75 days gestation (term = 145 days), when ASMA-positive cells are absent, but excisional wounds begin to contract and show some scar formation beginning at 100 days gestation, when ASMA-positive myofibroblasts first appear. Transmission electron microscopy studies show that early in development, microfilament bundles in fibroblasts are sparse and disorganized, but as gestation progresses, the bundles became more prevalent and form tightly parallel arrangements characteristic of the contractile machinery of myofibroblasts. 23 The acquisition of more smooth muscle-like elements in wound fibroblasts later in gestation implies a relationship to the development of scar seen at that time. Within either the late gestation fetal wound or the adult wound, the forces of wound contraction generated by myofibroblasts and the "stiffer" matrix that is present can alter the alignment of collagen fibrils leading to the early establishment of an abnormal, scar-like orientation. Recent studies have focused on the principal components of the fetal dermal matrix -collagen and proteoglycans produced by the fetal fibroblast.
THE FETAL WOUND MATRIX
The extracellular matrix is a complex, cross-linked structure of proteins and polysaccharides that surrounds cells and organizes the geometry of normal tissues. Fetal wounds synthesize most ofthe matrix molecules present in adult wounds, but there are differences in the timing and pattern of these molecules in fetal wounds. For example, the cell adhesion molecule called tenascin is deposited much more rapidly and persists longer in fetal wounds, perhaps accounting for the rapid epithelialization and cellular ingrowth that occurs in fetal wound healing. 24 Collagen is an important component ofthe extracellular matrix; a scar is defined as abnormal collagen organization after wound repair compared with normal surrounding tissue. Thus, the pattern of collagen deposition in fetal and adult wounds is of particular interest. The orderly deposition of collagen in fetal animal models has been demonstrated using histologic, immunohistochemical, biochemical, and biophysical techniques.25 The collagen pattern in fetal wounds is reticular and indistinVol. 220 -No.-1 guishable from adjacent normal tissue, whereas the adult wound contains large, parallel collagen bundles that are oriented perpendicular to the wound surface.'0 Thus, scarless fetal wound healing must reflect the organization of collagen, not the absence of collagen in the fetal wound matrix.
Although collagen types I, III, V, and VI are present in both fetal and adult wounds,'0'26 there are a few known differences in dermal collagen between the fetus and the adult. The presence of aminopropeptides of type I collagen in heterogeneous collagen fibrils is more common in the fetus compared with the adult.27 The fetal dermis also contains a preponderance of type III collagen,28 and as the fetus develops, the ratio of type III/type I collagen decreases, which may influence collagen fibril size. Small diameter collagen I fibrils with a high turnover and a similar configuration to fetal collagen (in terms of attached type III collagen and presence of type I aminopropeptide) occur adjacent to the epidermal/dermal junction in adult skin,27 which is the region that shows minimal scarring in adult wounds. These minor differences between collagen in the fetal and adult dermis may be important in modulating the nature of the wounding response.
Alterations in the synthesis of proteoglycans and their constituent glycosaminoglycans correlate with the cell proliferation, migration, and collagen synthesis that accompany adult wound healing.29 Proteoglycans are a heterogeneous group of polyanionic macromolecules that consist ofa protein core, to which a variable number of linear, sulfated glycosaminoglycan chains are bound covalently. These macromolecules include versican, a large chondroitin sulfate proteoglycan; decorin, a small dermatan sulfate proteoglycan; and heparan sulfate proteoglycan. Proteoglycans and glycosaminoglycans have been shown to affect wound collagen organization and fibrillogenesis, and by binding to specific binding sites on collagen, control its rate of degradation.30 The sulfated glycosaminoglycans temporally follow hyaluronic acid in the adult healing process, and the decline of hyaluronic acid levels and the appearance of sulfated glycosaminoglycans have been shown in several embryologic systems to correlate with the onset ofcytodifferentiation.3'
The fetal wound matrix is rich in glycosaminoglycans -in fetal rabbit wounds, the glycosaminoglycan content is approximately 3 times that ofthe adult wound during the same time period, and approximately 10 times that found in fetal skin that is not wounded.32 Hyaluronic acid (HA), the principal glycosaminoglycan present in fetal wounds, is a large molecule composed of alternating units of glucuronic acid and N-acetylglucosamine. An HA-rich matrix is permissive for cell motility and proliferation, and a prolonged presence of HA in fetal wounds may provide the matrix signal that orchestrates healing by regeneration. Mammalian HA also has associated binding proteins, which have been implicated in the biologic activity of HA.33 Fetal wound fluid, fetal urine, and amniotic fluid have the ability to stimulate and sustain HA synthesis because ofa unique hyaluronic acid-stimulating activity. Recent support for the important role of HA in the fetal wound healing process is that levels of both HA and hyaluronic acid-stimulating activity in fetal lamb wound fluid decrease significantly during the transition period from fetal-like to adult healing at 120 days gestation in fetal sheep. 34 Similarly, there is a gestational age-dependent decrease in both total glycosaminoglycan and HA content in normal fetal sheep skin, and the temporal appearance of extracellular decorin and heparan sulfate proteoglycan coincides with the onset of scarring that begins during late gestation.34 Finally, chondroitin sulfate proteoglycan is present within fetal mouse wounds at the time of collagen fibril formation, but it is absent at that time in adult mouse wounds. 26 Thus, HA and chondroitin sulfate are likely important for scar-free repair, whereas other sulfated glycosaminoglycans may play a role in scar formation.
The primary wound "scaffolding" into which fibroblasts migrate has a very important influence on collagen fibrillogenesis. In the fetal wound, fibroblasts can migrate rapidly into a loose honeycomb matrix containing high levels of hyaluronic acid. In contrast, adult wounds exhibit slow fibroblast migration into a denser, more resistant wound matrix where fibroblast migration occurs more easily along the wound margins. These initial differences in the migration and orientation of fibroblasts may establish the pattern of collagen fibrils deposited in the respective wounds, with a loose reticular structure in the fetus and a closely packed, disorganized arrangement in the adult.
THE ROLE OF INFLAMMATION AND CYTOKINES
There are major differences in the degree of inflammation in fetal and adult wounds. Until mid-gestation, the fetus is significantly neutropenic and has not developed self/non-self immunologic identity.36 Histologically, there are very few, if any, polymorphonuclear leukocytes in fetal wounds,37 and there may be a defect in immature polymorphonuclear leukocyte chemotactic ability.38 Recent studies have correlated the absence of scarring in fetal wounds with the sparse inflammatory response, as evidenced by markedly reduced macrophage and monocyte infiltrates,7 absence of endogenous immunoglobulins at the wound site,'0'25 reduced angiogenesis, and altered levels of peptide growth factors. 39 The transition of the fetal healing phenotype to a scarring, adult phenotype in the marsupial correlates directly with the amount of inflammatory reaction at the wound site.40 These studies suggest that immature fetal immune cells do not respond to the wounding stimulus in a similar fashion to adult cells.
Peptide growth factors are released by inflammatory cells and help provide a cell-to-cell and cell-to-matrix communication system. These cytokines can affect matrix synthesis, matrix degradation, cell proliferation, and cell recruitment to the wound site. Because of the prominent role that inflammation plays in adult tissue repair, the characteristic inflammatory mediators of adult wound healing may be absent or modified in fetal wounds. A different cytokine profile in fetal wounds, a consequence of the relative lack of inflammatory cells, can cause matrix molecule differences that lead to scarfree healing.
TRANSFORMING GROWTH FACTOR-

BETA (TGF-0)
Of the many cytokines that have been implicated in wound healing, TGF-f affects all phases of the healing process, including the inflammatory response and matrix accumulation.4' In the adult wound, the macrophage is a crucial inflammatory cell that releases TGFf and other cytokines. The mammalian TGF-fl family consists ofthree known isoforms, TGF-, 1, TGF-f2, and TGF-fl3, that are structurally and functionally closely related to one another. Through autocrine and paracrine mechanisms, TGF-,B stimulates the deposition of collagen and other matrix components by fibroblasts, inhibits collagenase, blocks plasminogen inhibitor, enhances angiogenesis, and is chemotactic for fibroblasts, monocytes and macrophages.42 Thus, TGF-,B is capable of stimulating fibrogenesis by the fibroblast.
Transforming growth factor-: may provide the link between injury, inflammation, and fibrosis. After tissue injury, activated macrophage-derived TGF-f disturbs the balance ofsynthesis and degradation ofcollagens and causes accumulation ofextracellular matrix. Transforming growth factor-,B induces alpha-smooth muscle actin expression in fibroblasts, and this finding correlates with scar formation and pathologic wound contraction. 43 The ability of TGF-f to induce its own production may be crucial for the development of progressive scarring in chronic diseases that lead to eventual obliteration ofnormal tissue architecture. The correlation between TGF-f levels and scar formation holds true for a variety of fibrotic diseases. Experimental intraperitoneal administration of TGF-f results in adhesion formation. 44 There is enhanced expression of TGF-f 1 at the site of scar in the rat brain after localized cerebral injury.45 In proliferative vitreoretinopathy, total TGF-f levels in intraocular fluid increase as the retinal scarring progresses from mild to moderate to severe. 46 Markedly increased amounts of TGF-f are present in fibrogenic diseases such as cirrhosis,47 interstitial pulmonary fibrosis,48 glomerulonephritis,49,50 and scleroderma.5' Exogenously applied TGF-# promotes scar formation in both adult and fetal wounds. Specifically, the addition ofTGF-,B to polyvinyl alcohol sponges implanted in fetal rabbits produces fibrosis. 52 We have demonstrated that when TGF-f is added to human fetal skin wounds via a slow release disk, scar formation results. 53 In vitro studies have shown that exposure of fetal dermal fibroblasts to TGF-f results in marked upregulation of collagen gene expression.54 Thus, the cellular and matrix machinery that is necessary for scar formation exists in fetal wounds.
Fibroblasts are not only capable of responding to the numerous cytokines produced by the immune system, but they can synthesize and secrete, on their own, growth factors with pleotrophic effects. The technique of reverse transcription-polymerase chain reaction was used to detect differences in TGF-fl-specific mRNA production by fetal and adult sheep fibroblasts.55 To test whether fetal and adult fibroblasts have different responses to the low tissue pO2 in the fetal wound environment, we examined TGF-# 1 gene expression in these cells under normoxic and hypoxic conditions. Both fetal and adult fibroblasts showed the potential to produce TGF-, 1 at normoxia, but fetal fibroblasts responded to hypoxia with a decrease in TGF-f 1 transcription, whereas adult fibroblasts were stimulated by hypoxia to increase TGF-# transcription. Thus, the low fetal wound pO2 may markedly downregulate TGF-f 1 gene expression. is released from the alpha-granules of activated platelets, so it also is possible that fetal platelets may not synthesize or release TGF-f at the fetal wound site. The relative lack of TGF-f, a cytokine known to induce fibrosis, may be an important reason the fetus heals by regeneration rather than by scarring. Transforming growth factor-: may be important in adult tissue repair, but excessive action of this cytokine may be responsible for the tissue damage caused by scarring in many serious diseases. These findings suggest that anti-TGF-,B therapeutic strategies may ameliorate scar formation in adult fibrotic diseases.
CYTOKINE EXCESS IN ADULT WOUNDS
Shah and colleagues mimicked this fetal wound situation within the healing adult rat wound by using an anti-TGF-,B polyclonal neutralizing antibody to experimentally reduce TGF-, levels.57 This manipulation resulted in markedly diminished scarring in adult wounds. The neutralizing antibody-treated wounds had normal tensile strength and a nearly normal dermal architecture compared with untreated wounds, and this salutary effect was accompanied by deposition of less collagen and fibronectin and infiltration by fewer macrophages and blood vessels. Injection of TGF-f alone had the opposite effects. Application of TGF-f neutralizing antibody at the time of wounding (and not later) was essential to reduce active TGF-# levels, prevent auto-induction ofTGF-f mRNA, and limit macrophage infiltration and further TGF-f release. The effectiveness of this approach has been demonstrated in another fibrotic process, because administration ofeither TGF-f 1 antiserum or decorin to neutralize TGF-f biologic activity suppresses the pathologic increase in matrix synthesis that occurs in an animal model of glomerulonephritis.4950 Thus, the relationship of TGF-# to scar formation fulfills Koch's postulates -TGF-f is absent in scarless fetal wounds, addition of TGF-f to fetal wounds results in scar formation, the presence of TGF-# after adult injury correlates with the degree offibrosis observed, and blocking of TGF-f in adult wounds has a potent anti-scarring effect.
Subsequent studies by Shah and Ferguson have shown that neutralization of both TGF-f 1 and TGF-#2 isoforms has a much greater, synergistic anti-scarring effect than neutralization of either isoform alone.58 Neutraliz- ing antibodies against platelet-derived growth factor also have some anti-scarring effect, but antibodies to epidermal growth factor have no effect on dermal scarring.59
Although injection of cytokine antibodies into wounds has very limited clinical potential because ofantigenicity problems, there are other promising ways to reduce wound levels of TGF-f1 and TGF-f2. Addition of the IV and laminin, normal components of the endothelial basement membrane, shows profuse angiogenesis in adult wounds, whereas fetal wounds have a diminished vascular pattern similar to adjacent undamaged fetal tissue.0'26 A more rapid rate of adult wound neovascularization would bring earlier wound perfusion by adult serum and inflammatory cells, thereby contributing to a scar repair pattern.
In evolutionary terms, it appears that adult wounds may be optimized for speed of healing under adverse conditions (dirt, foreign bodies, etc.) and the result is an excessive inflammatory infiltrate and cytokine profile. The potential fetal regenerative response in adult wounds may be overrun by an inflammation-induced cytokine surplus leading to scar. This phenomena is an example of"cytokine poisoning," in which the inappropriate reparative response of the patient may prove det- There are a number ofways in which the matrix and cellular response of the healing adult wound might be manipulated to reduce scarring -i.e., inhibiting the wound inflammatory response by blocking inflammatory cytokines such as TGF-f,, basic fibroblast growth factor, and platelet-derived growth factor; adding exogenous tenascin to facilitate keratinocyte and fibroblast migration into the wound; transplanting fibroblasts with fetal characteristics to the adult wound site; providing a more porous wound scaffold by addition of hyaluronic acid or hyaluronic acid-stimulating activity to enhance fibroblast migration and promote regeneration of a normal reticular collagen organization in the wounded dermis. Although all of these potential therapeutic strategies require rigorous scientific testing, adult wound healing may be altered toward a scar-free, fetal-like phenotype by modifying one or more of the components that are different between fetal and adult repair.
